Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 342articles · 30d
- 59+ min agolatest article
- Aug 17, 2026earliest in window
- 92%with images
- 291avg words
- Economy, Business & Finance 196
- Health & Wellness 160
- Medical 158
- Business & Industrial 143
- Finance & Business 132
- Health 75
- Science & Technology 54
- Science & Nature 35
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
TAGRISSO?? (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial
2+ hour, 52+ min ago (605+ words) Longest survival data ever reported in a global Phase III trial in this setting New data reinforce TAGRISSO as the standard of care and backbone therapy in EGFRm lung cancer across stages These results were presented today during the Presidential…...
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
1+ hour ago (544+ words) BioSpace Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation The Initiative Will Make Available 100,000 Disease-Specific Whole Genome Sequences Paired with Longitudinal Clinical Outcomes, with a Long-Term Goal of Reaching 1 Million Genomes CHICAGO--(BUSINESS…...
TAE Life Sciences Achieves ISO 13485 Certification, Marking a Major Milestone in Quality and Regulatory Excellence
3+ day, 2+ min ago (137+ words) Audit Concluded with Zero Findings, Underscoring the Company's Commitment to Patient Safety and Medical Device Quality A Defining Milestone for TAE Life Sciences The certification was awarded following a comprehensive audit conducted by BSI (British Standards Institution), a globally recognized…...
IMDS Launches NHanceIT™ Microcatheter in the U.S. to Advance Complex PCI
3+ day, 19+ min ago (211+ words) Proprietary Skeleton Backbone™ technology introduces a new approach to catheter design to address the growing complexity in coronary interventions Powered by proprietary Skeleton Backbone technology, NHanceIT maintains force transmission from hub to distal end. True 1:1 torque response and reinforced metal…...
Three Life-Saving Medical Technologies Named Finalists for the Second Annual Thomas J. Fogarty Innovation Prize
3+ day, 20+ min ago (335+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...
Incyte Announces Funding of MINJUVI® (tafasitamab) for patients with Relapsed or Refractory Follicular Lymphoma through Ontario's FAST Program
3+ day, 42+ min ago (346+ words) Despite advances in care, most patients with FL eventually experience relapse, highlighting the need for additional treatment options across multiple lines of therapy.3 The acceptance of cancer therapies such as MINJUVI® in the treatment of FL represents a significant step,…...
Olympus Announces New Class of iTind™ Center of Excellence Program Physicians
3+ day, 1+ hour ago (457+ words) Program Aims to Advance Minimally Invasive Treatment of Enlarged Prostate CENTER VALLEY, Pa., Sept. 10, 2026 /PRNewswire/ -- Olympus Corp. of the Americas (Olympus) is pleased to announce the newest members of the iTind™ Center of Excellence (COE) Program, which is designed to…...
Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline
3+ day, 16+ hour ago (429+ words) BioSpace Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline CAMBRIDGE, England--(BUSINESS WIRE)--Clinical-stage biotech Alchemab Therapeutics has appointed experienced pharma and biotech leader Dr Ben Porter-Brown as Chief…...
Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs
3+ day, 11+ hour ago (140+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...
Biohaven takes another hit as FDA pauses enrollment in pivotal trials for embattled epilepsy drug
3+ day, 17+ hour ago (274+ words) Biohaven stock fell more than 13% in premarket trading Thursday as the FDA slapped a partial clinical hold on its Kv7 potassium channel agonist in focal epilepsy. This latest development comes days after SK Biopharmaceuticals snagged a worldwide license to the Kv7 platform,…...